See more : Sagarsoft (India) Limited (SAGARSOFT.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Nutriband Inc. (NTRBW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nutriband Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Abcam plc (ABCM) Income Statement Analysis – Financial Results
- Ausgold Limited (AUC.AX) Income Statement Analysis – Financial Results
- Dr. Soliman Abdel Kader Fakeeh Hospital Company (4017.SR) Income Statement Analysis – Financial Results
- Molson Coors Beverage Company (TAP-A) Income Statement Analysis – Financial Results
- PostNL N.V. (PSTNY) Income Statement Analysis – Financial Results
Nutriband Inc. (NTRBW)
About Nutriband Inc.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.09M | 2.08M | 1.42M | 943.70K | 370.65K | 245.29K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.22M | 1.33M | 917.84K | 582.38K | 549.11K | 288.30K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 862.11K | 750.41K | 504.31K | 361.32K | -178.46K | -43.02K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 41.34% | 36.08% | 35.46% | 38.29% | -48.15% | -17.54% | 0.00% | 0.00% | 0.00% |
| Research & Development | 1.96M | 982.23K | 411.38K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 4.02M | 2.91M | 0.00 | 0.00 | 0.00 | 143.49K | 4.80K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 45.00K | 0.00 | 0.00 | 0.00 | 7.77K | -4.40K |
| SG&A | 3.77M | 3.92M | 4.02M | 2.96M | 1.79M | 3.29M | 171.95K | 151.26K | 400.00 |
| Other Expenses | 0.00 | 327.33K | 2.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 5.73M | 4.90M | 4.43M | 2.96M | 1.79M | 3.29M | 171.95K | 151.26K | 400.00 |
| Cost & Expenses | 6.96M | 6.23M | 5.35M | 3.54M | 2.34M | 3.58M | 171.95K | 151.26K | 400.00 |
| Interest Income | 16.85K | 8.29K | 118.42K | 280.69K | 73.41K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 75.82K | 8.29K | 118.42K | 280.69K | 73.41K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 287.72K | 368.96K | 318.26K | 169.72K | 91.84K | 37.01K | 147.26K | 151.26K | 4.80K |
| EBITDA | -5.12M | -4.11M | -5.74M | -2.48M | -2.56M | -3.29M | -2.67M | 0.00 | -400.00 |
| EBITDA Ratio | -245.61% | -181.71% | -253.96% | -264.42% | -506.69% | -1,343.02% | 0.00% | 0.00% | 0.00% |
| Operating Income | -4.87M | -4.15M | -3.93M | -2.60M | -1.97M | -3.33M | -171.95K | -151.26K | -400.00 |
| Operating Income Ratio | -233.63% | -199.45% | -276.33% | -275.08% | -531.35% | -1,358.11% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -613.39K | -335.62K | -2.25M | -336.88K | -752.19K | 0.00 | -2.50M | 0.00 | 0.00 |
| Income Before Tax | -5.49M | -4.48M | -6.18M | -2.93M | -2.72M | -3.33M | -2.67M | -151.26K | -400.00 |
| Income Before Tax Ratio | -263.04% | -215.59% | -434.28% | -310.78% | -734.29% | -1,358.11% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 327.33K | 2.25M | 280.69K | 73.41K | -124.13K | 2.35M | -151.26K | -4.80K |
| Net Income | -5.49M | -4.81M | -8.42M | -3.21M | -2.80M | -3.33M | -2.67M | -151.26K | -400.00 |
| Net Income Ratio | -263.04% | -231.33% | -592.23% | -340.52% | -754.10% | -1,358.11% | 0.00% | 0.00% | 0.00% |
| EPS | -0.69 | -0.57 | -1.06 | -0.48 | -0.44 | -0.53 | -0.48 | -0.03 | 0.00 |
| EPS Diluted | -0.69 | -0.57 | -1.06 | -0.48 | -0.44 | -0.53 | -0.48 | -0.03 | 0.00 |
| Weighted Avg Shares Out | 7.95M | 8.46M | 7.93M | 6.73M | 6.33M | 6.24M | 5.60M | 6.06M | 6.06M |
| Weighted Avg Shares Out (Dil) | 7.95M | 8.46M | 7.93M | 6.73M | 6.33M | 6.24M | 5.60M | 6.06M | 6.06M |
Nutriband Inc. to Present at the Emerging Growth Conference on May 25
Nutriband Stock (NTRB): Why The Price Surged Today
Source: https://incomestatements.info
Category: Stock Reports